Literature DB >> 29106910

The role of mucus on drug transport and its potential to affect therapeutic outcomes.

Xabier Murgia1, Brigitta Loretz1, Olga Hartwig1, Marius Hittinger2, Claus-Michael Lehr3.   

Abstract

A layer of mucus covers the surface of all wet epithelia throughout the human body. Mucus is a hydrogel mainly composed of water, mucins (glycoproteins), DNA, proteins, lipids, and cell debris. This complex composition yields a tenacious viscoelastic hydrogel that lubricates and protects the exposed epithelia from external threats and enzymatic degradation. The natural protective role of mucus is nowadays acknowledged as a major barrier to be overcome in non-invasive drug delivery. The heterogeneity of mucus components offers a wide range of potential chemical interaction sites for macromolecules, while the mesh-like architecture given to mucus by the intermolecular cross-linking of mucin molecules results in a dense network that physically, and in a size-dependent manner, hinders the diffusion of nanoparticles through mucus. Consequently, drug diffusion, epithelial absorption, drug bioavailability, and ultimately therapeutic outcomes of mucosal drug delivery can be attenuated.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Hydrogel; Mucins; Mucoadhesion; Mucopenetration; Mucosal drug delivery; Nanoparticles; PEGylation; Rheology

Mesh:

Substances:

Year:  2017        PMID: 29106910     DOI: 10.1016/j.addr.2017.10.009

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  39 in total

1.  Structure-Stability-Function Mechanistic Links in the Anti-Measles Virus Action of Tocopherol-Derivatized Peptide Nanoparticles.

Authors:  Tiago N Figueira; Diogo A Mendonça; Diana Gaspar; Manuel N Melo; Anne Moscona; Matteo Porotto; Miguel A R B Castanho; Ana Salomé Veiga
Journal:  ACS Nano       Date:  2018-09-24       Impact factor: 15.881

2.  Molecular Characterization of Mucus Binding.

Authors:  Jacob Witten; Tahoura Samad; Katharina Ribbeck
Journal:  Biomacromolecules       Date:  2019-03-12       Impact factor: 6.988

Review 3.  Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.

Authors:  Ze-Liang Wu; Jun Zhao; Rong Xu
Journal:  Int J Nanomedicine       Date:  2020-12-01

4.  Disease Models: Lung Models for Testing Drugs Against Inflammation and Infection.

Authors:  Patrick Carius; Justus C Horstmann; Cristiane de Souza Carvalho-Wodarz; Claus-Michael Lehr
Journal:  Handb Exp Pharmacol       Date:  2021

Review 5.  Primary Cell-Derived Intestinal Models: Recapitulating Physiology.

Authors:  Johanna S Dutton; Samuel S Hinman; Raehyun Kim; Yuli Wang; Nancy L Allbritton
Journal:  Trends Biotechnol       Date:  2018-12-24       Impact factor: 19.536

Review 6.  Engineering Strategies for Oral Therapeutic Enzymes to Enhance Their Stability and Activity.

Authors:  Philipp Lapuhs; Gregor Fuhrmann
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

7.  Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer.

Authors:  Ashok K Dilly; Brendon D Honick; Robin Frederick; Anuleka Elapavaluru; Sachin Velankar; Hima Makala; T Kevin Hitchens; Lesley M Foley; Jianxia Guo; Jan H Beumer; Lora Heather Rigatti; Yong J Lee; David L Bartlett; Haroon A Choudry
Journal:  Transl Res       Date:  2020-10-22       Impact factor: 7.012

8.  Surfactant-Free Glibenclamide Nanoparticles: Formulation, Characterization and Evaluation of Interactions with Biological Barriers.

Authors:  Eva C Arrua; Olga Hartwig; Duy-Khiet Ho; Brigitta Loretz; Xabier Murgia; Claudio J Salomon; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2021-05-17       Impact factor: 4.200

9.  Spatial configuration of charge and hydrophobicity tune particle transport through mucus.

Authors:  Tahoura Samad; Jacob Witten; Alan J Grodzinsky; Katharina Ribbeck
Journal:  Biophys J       Date:  2021-12-21       Impact factor: 4.033

Review 10.  Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases.

Authors:  Zicheng Deng; Gregory T Kalin; Donglu Shi; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.